Skip to content

Assessment of an Endotracheal Tube Securement Device

Assessment of the Functionality and Performance of an Endotracheal (ET) Tube Protection Device

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01651260
Enrollment
65
Registered
2012-07-27
Start date
2012-07-31
Completion date
2013-02-28
Last updated
2016-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Insufficiency

Brief summary

Endotracheal intubation is the translaryngeal placement of a tube into the trachea via the nose or mouth. Endotracheal tubes must be securely fixed to prevent movement, which may result in accidental slippage of the tube into a mainstream bronchus or into the pharynx. Hollister Incorporated is assessing the functionality and performance of an endotracheal tube securement device.

Detailed description

This was a multiple site assessment of the Anchor Fast with enhanced tube protection. Subjects already intubated who required a change of tube-securing device or subjects requiring intubation for greater than 24 hours who meet the inclusion and exclusion criteria were eligible to enroll into the study.The study was open to adult subjects without an existing neck injury who required oral tracheal intubation for greater than 24 hours. Subjects were required to have intact skin on the application site and to be free of facial hair, damaged skin or conditions on the application site (e.g. sunburn, scars, moles or other disfigurations), and significant skin diseases on the application site (e.g. psoriasis, eczema, atopic dermatitis, active cancer) which may have contraindicated participation.

Interventions

OTHERExperimental ET Tube Securement Device

Experimental Hollister device with bite block was substituted for standard-of-care device during the study period.

Sponsors

Hollister Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Is 18 years of age or older; male or female and requiring oral tracheal intubation. * Has intact skin on application site. * Willingly signs or their authorized representative willingly signs the Informed Consent. * Is qualified to participate in the opinion of the Investigator.

Exclusion criteria

* Has an existing neck injury. * Has protruding upper teeth, without teeth or is unable to wear upper dentures. * Has facial hair. * Has clinically significant skin diseases on the application site which may contraindicate participation, including psoriasis, eczema, atopic dermatitis, active cancer. * Has damaged skin or conditions on the application site which includes sunburn, scars, moles or other disfiguration of the test site. * Has a known or stated allergy to adhesive bandages, or any of the product types being tested. * Uses of topical drugs on the application site. * Uses lotions, creams or oils on the application site. * Currently is participating in any clinical testing which may affect performance of this device. * Has been previously intubated with skin irritation or pressure sores surrounding the mouth.

Design outcomes

Primary

MeasureTime frameDescription
Prevention of Damage and/or Occlusion of Endotracheal (ET) Tube During Use14 daysNumber of participants with damage of ET tube and Number of participants with occlusion of ET tube

Secondary

MeasureTime frameDescription
Ease of UseBetween 1 - 14 daysLikert scale score provided by clinician (1 very difficult, 2 difficult, 3 neither easy nor difficult, 4 easy, 5 very easy);

Countries

United States

Participant flow

Recruitment details

Subjects were recruited between July 2012 to February 2013 in the ICU setting at 6 hospitals.

Participants by arm

ArmCount
Hollister ET Tube Securement Device
Hollister endotracheal tube securement device: Subjects wear one Hollister ET tube securement device until the device either needs to be changed or is no longer required by the subject.
63
Total63

Withdrawals & dropouts

PeriodReasonFG000
Overall Studyunable to apply product3

Baseline characteristics

CharacteristicHollister ET Tube Securement Device
Age, Continuous57.8 years
STANDARD_DEVIATION 15.6
Reason for intubation
Other
5 participants
Reason for intubation
Post-operative
3 participants
Reason for intubation
Respiratory Failure
55 participants
Sex: Female, Male
Female
28 Participants
Sex: Female, Male
Male
35 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
4 / 65
serious
Total, serious adverse events
4 / 65

Outcome results

Primary

Prevention of Damage and/or Occlusion of Endotracheal (ET) Tube During Use

Number of participants with damage of ET tube and Number of participants with occlusion of ET tube

Time frame: 14 days

ArmMeasureGroupValue (NUMBER)
Hollister Endotracheal (ET) Tube Securement DevicePrevention of Damage and/or Occlusion of Endotracheal (ET) Tube During UseDamage to ET tube0 participants
Hollister Endotracheal (ET) Tube Securement DevicePrevention of Damage and/or Occlusion of Endotracheal (ET) Tube During UseOcclusion of ET Tube1 participants
Secondary

Ease of Use

Likert scale score provided by clinician (1 very difficult, 2 difficult, 3 neither easy nor difficult, 4 easy, 5 very easy);

Time frame: Between 1 - 14 days

ArmMeasureValue (NUMBER)
Hollister Endotracheal (ET) Tube Securement DeviceEase of Use63 % rating with score of 4 and 5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026